We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M Turnover 56.25%
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+16.82%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$37M
Cap. Flow
-$42.8M
Cap. Flow %
-37.45%
Top 10 Hldgs %
55.88%
Holding
85
New
18
Increased
11
Reduced
34
Closed
19
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$3.67M
2
FLNA icon
Filana Therapeutics
FLNA
+$3.22M
3
CYNI
CYAN INC COM
CYNI
+$2.12M
4
BEAT icon
BioTelemetry, Inc.
BEAT
+$2.04M
5
MNDT
Mandiant, Inc. Common Stock
MNDT
+$1.32M

Top Sells

Rank Stock Value
1
SIGA icon
SIGA Technologies
SIGA
+$4.46M
2
AVAV icon
AeroVironment
AVAV
+$4.42M
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$4.02M
4
CALX icon
Calix
CALX
+$3.41M
5
SANW icon
S&W Seed Co
SANW
+$3.17M

Sector Composition

Rank Sector Weight
1 Healthcare 55.14%
2 Technology 27.01%
3 Communication Services 7.3%
4 Utilities 3.32%
5 Miscellaneous 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BEAT icon
1
DELISTED
BioTelemetry, Inc.
BEAT
$9.78M 8.57%
1,231,718
+218,400
+22% +$2.04M
2013 Q2
2 quarters
ZLTQ
2
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$9.62M 8.43%
508,904
-110,700
-18% -$1.58M
2013 Q2
2 quarters
MSTR icon
3
Strategy Inc
MSTR
$64.1B
$7.41M 6.49%
596,630
-230,000
-28% -$2.71M
2013 Q2
2 quarters
LSAK icon
4
Lesaka Technologies
LSAK
$382M
$6.17M 5.4%
706,466
-142,300
-17% -$1.51M
2013 Q2
2 quarters
CALX icon
5
Calix
CALX
$2.34B
$6.16M 5.4%
639,165
-318,641
-33% -$3.41M
2013 Q2
2 quarters
FLNA icon
6
Filana Therapeutics
FLNA
$36.8M
$6.15M 5.38%
180,717
+121,315
+204% +$3.22M
2013 Q3
1 quarter
ARCT icon
7
Arcturus Therapeutics
ARCT
$320M
$5.77M 5.05%
45,768
+29,232
+177% +$3.67M
2013 Q3
1 quarter
ARAY icon
8
Accuray
ARAY
$20.8M
$4.61M 4.04%
529,500
-20,900
-4% -$162K
2013 Q2
2 quarters
BDSI
9
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.09M 3.58%
694,962
-779,944
-53% -$4.02M
2013 Q2
2 quarters
MEET
10
DELISTED
The Meet Group, Inc. Common Stock
MEET
$4.05M 3.54%
2,210,887
-384,152
-15% -$716K
2013 Q2
2 quarters
PKT
11
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$3.79M 3.32%
252,090
-72,610
-22% -$1.05M
2013 Q2
2 quarters
TLPH icon
12
Talphera
TLPH
$55.5M
$3.72M 3.26%
16,469
-10,720
-39% -$1.86M
2013 Q2
2 quarters
PCYO icon
13
Pure Cycle
PCYO
$268M
$3.63M 3.18%
573,000
-96,436
-14% -$594K
2013 Q2
2 quarters
DRRX icon
14
DELISTED
DURECT Corp
DRRX
$3.14M 2.75%
181,397
-17,555
-9% -$265K
2013 Q3
1 quarter
AXGN icon
15
Axogen
AXGN
$2.09B
$2.83M 2.48%
631,607
-124,121
-16% -$504K
2013 Q3
1 quarter
P icon
16
DELISTED
Pandora Media Inc
P
$2M 1.75%
75,200
-22,000
-23% -$603K
2013 Q2
2 quarters
CSII
17
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.95M 1.71%
56,941
-74,600
-57% -$2.17M
2013 Q2
2 quarters
UI icon
18
Ubiquiti
UI
$37.4B
$1.95M 1.71%
42,463
-68,600
-62% -$2.73M
2013 Q2
2 quarters
CYNI
19
DELISTED
CYAN INC COM
CYNI
$1.88M 1.64%
+354,699
New +$2.12M
2013 Q4
0 quarters
STRM icon
20
DELISTED
Streamline Health Solutions
STRM
$1.6M 1.4%
15,320
+5,673
+59% +$623K
2013 Q2
2 quarters
ENVI
21
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$1.59M 1.39%
466,022
+26,071
+6% +$78.5K
2013 Q2
2 quarters
CUTR icon
22
DELISTED
Cutera, Inc.
CUTR
$1.57M 1.37%
154,089
-170,248
-52% -$1.6M
2013 Q2
2 quarters
ARWR icon
23
Arrowhead Research
ARWR
$8.26B
$1.53M 1.34%
140,858
-153,725
-52% -$1.23M
2013 Q3
1 quarter
MNDT
24
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1.47M 1.29%
+33,700
New +$1.32M
2013 Q4
0 quarters
ENT
25
DELISTED
Global Eagle Entertainment Inc.
ENT
$1.44M 1.26%
3,872
+3,020
+354% +$926K
2013 Q3
1 quarter
1
2 3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Sophrosyne Capital held 85 positions worth $114M, down 24% from $151M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sophrosyne Capital withdrew a net $42.8M in Q4 2013, closing 19 positions and reducing 34 holdings. Its most notable exit was SIGA Technologies, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 50% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in CYAN INC COM worth $1.88M.

  • Sophrosyne Capital's largest Q4 2013 buy was CYAN INC COM: 354,699 shares worth $1.88M.
  • Sophrosyne Capital added most to Arcturus Therapeutics in Q4 2013, an estimated $3.67M increase.
  • Sophrosyne Capital's biggest Q4 2013 reduction was AeroVironment, cutting an estimated $4.42M.
  • Sophrosyne Capital fully exited SIGA Technologies in Q4 2013, selling an estimated $4.46M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $114M portfolio in Q4 2013.
  • Sophrosyne Capital opened 18 new positions and closed 19 in Q4 2013.
  • Sophrosyne Capital's portfolio value fell 24% quarter-over-quarter to $114M.

Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.